Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study

(2011) Osnat Bairey et al.   ANNALS OF HEMATOLOGY

Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters

(2010) R. Letestu et al.   BLOOD

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

(2010) Tait D. Shanafelt et al.   CANCER

Senescent cells as a source of inflammatory factors for tumor progression

(2010) Albert R. Davalos et al.   CANCER AND METASTASIS REVIEWS

Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β2-microglobulin in B-cell chronic lymphocytic leukemia

(2010) Stefano Molica et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2

(2010) A. Schulz et al.   HAEMATOLOGICA

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

(2009) J. A. Burger et al.   BLOOD

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

(2009) A. V. Kurtova et al.   BLOOD

Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate

(2009) Julio Delgado et al.   BRITISH JOURNAL OF HAEMATOLOGY

Predictive value of  2-microglobulin ( 2-m) levels in chronic lymphocytic leukemia since Binet A stages

(2009) M. Gentile et al.   HAEMATOLOGICA

Characteristics Associated With Important Clinical End Points in Patients With Chronic Lymphocytic Leukemia at Initial Treatment

(2009) William G. Wierda et al.   JOURNAL OF CLINICAL ONCOLOGY

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles

(2009) M Plander et al.   LEUKEMIA

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort

(2009) M.D. Seftel et al.   LEUKEMIA RESEARCH

Telomere length measurement by a novel monochrome multiplex quantitative PCR method

(2009) R. M. Cawthon   NUCLEIC ACIDS RESEARCH

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

(2008) L. Z. Rassenti et al.   BLOOD

The immunodeficiency of chronic lymphocytic leukaemia

(2008) A. D. Hamblin et al.   BRITISH MEDICAL BULLETIN

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

Adipose Tissue: The New Endocrine Organ? A Review Article

(2008) Susan E. Wozniak et al.   DIGESTIVE DISEASES AND SCIENCES